Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bites and Stings × Bupivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 25 Breast Neoplasms 21 Lung Neoplasms 10 Pain 9 Agnosia 9 Leiomyoma 6 Pancreatic Neoplasms 5 Neoplasms 5 Colorectal Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neuralgia 3 Hot Flashes 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Neuroma 2 Kidney Neoplasms 2 Ileus 2 Hyperparathyroidism 2 Goiter 2 Digestive System Diseases 2 Colonic Neoplasms 2 Chronic Pain 2 Breast Cancer Female 2 Brain Neoplasms 2 Abdominal Cancer 2 post laminectomy syndrome 1 Vesico-Ureteral Reflux 1 Uterine Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

pembrolizumab 3 enzalutamide 2 blinatumomab 2 abiraterone 2 Stents 2 Immune Checkpoint Inhibitors 2 Cytochrome P-450 Enzyme System 2 AMG 757 2 soybean oil, phospholipid emulsion 1 durvalumab 1 dostarlimab 1 cemiplimab 1 camrelizumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Radiotherapy, Conformal 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Palliative Care 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Neoadjuvant Therapy 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Immunotherapy 1 Hydroxyurea 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03165383 2017-05-24

TAP

Rajiv Gandhi Cancer Institute & Research Center, India

Phase NA Completed

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡